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Available online 25 August 2016We report on a 20-year-old patient with a 6-month history of recurrent abdominal pain and a 3-day history of
vomiting, hypertension, seizures, and encephalopathy. The brain MRI showed posterior reversible encephalopa-
thy syndrome, and continuous EEG (cEEG) monitoring showed lateralized periodic discharges plus fast activity.
Comprehensive CSF studies were negative. Because of severe abdominal pain without a deﬁnite etiology, we re-
quested urine porphobilinogen and serum and fecal porphyrins, which suggested acute intermittent porphyria
(AIP). The patient had a complete resolution of her symptoms with carbohydrate loading and high caloric
diet. Acute intermittent porphyria is potentially life-threatening without proper management and prevention
of triggers if it is not recognized.






Acute intermittent porphyria (AIP) is an autosomal dominant
disorder, which results from the partial deﬁciency of porphobilinogen
(PBG) deaminase, an enzyme of the heme biosynthesis pathway [1].
Symptoms of AIP include abdominal pain, nausea, vomiting, behavioral
changes, seizures, tachycardia, and hypertension [1]. There are previous
reports of AIP associated with posterior reversible encephalopathy
syndrome (PRES), which is thought to result from peaks in hyperten-
sion [2].
We report a case of a patient with severe recurrent abdominal pain
of unclear etiology, hypertension, tachycardia, and seizures, associated
with PRES on brain MRI and lateralized periodic discharges plus fast
activity (LPDs + F) [3] on continuous EEG monitoring (cEEG), who
was diagnosed with AIP.
2. Case presentation
This is a 20-year-old female with a 6-month history of recurrent
abdominal pain. She underwent cholecystectomy 3 months prior to
admission but had no relief of her symptoms. She was admitted with
acute pyelonephritis, nausea, vomiting, worsening of abdominal pain,
and constipation for three days. Her vital signs on admission showed),
. This is an open access article underuncontrolled hypertension (BP = 148/118 mm Hg) and tachycardia
(HR = 120 bpm). She was unable to eat during the last few days. On
the second day of her admission, she had two generalized tonic–clonic
seizures. She received lorazepamand levetiracetam, and her clinical sei-
zures resolved; however, she continued to be lethargic, and a stat EEG
was requested, that showed LPDs+F over the right temporoparietal re-
gion. The patient was transferred to the ICU for blood pressure control
and was started on treatment with acyclovir, antihypertensive medica-
tions, and antibiotics. She became profoundly lethargic and assumed a
fetal position in bed. On neurological examination, there were left
lower extremity clonus and a left Babinski sign. HeadCTwas normal, ce-
rebral spinal ﬂuid (CSF) was unremarkable, and comprehensive CSF
proﬁleswere negative, including PCR for Herpes Simplex virus, Varicella
Zoster virus, Lyme disease, and Cryptococcus. The brain MRI showed
PRES (Fig. 1). Because the stat EEG showed LPDs+ F, a highly epilepto-
genic pattern, cEEG was initiated to rule out the possibility of recurrent
electrographic seizures or nonconvulsive status epilepticus (Fig. 2).
There was one electrographic seizure arising from the right
temporoparietal region lasting less than 1 min seen during the ﬁrst
12 h of recording but none afterwards during the next two days of re-
cording. Therefore, clinical and electrographic seizures completely sub-
sided with treatment. Acyclovir was discontinued, and high dose
steroids were started, considering the possibility of immunological
and inﬂammatory etiologies. The patient showed clinical improvement,
but her abdominal pain persisted, and the diagnosis of an acute por-
phyria was suspected. Urine, then serum and fecal porphyrins were re-
quested. The results were as follows: urine PBG level was 177.4 μmol/Lthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Brain MRI scan, axial T2 FLAIR, shows faint multifocal and bilateral hyperintensities in the frontal lobes and parietooccipital lobes, extending to the left greater than right posterior
temporal regions.
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erence: 0 to 15 nmol/L), fecal coproporphyrin was 18 nmol/g (refer-
ence: 0 to 45 nmol/g), and fecal protoporphyrin was 10 nmol/g
(reference: 0–100 nmol/g). Taken together, the highly increased urine
PBG levels, slightly increased plasma porphyrin levels, and normal
fecal porphyrin levels, were suggestive of AIP. The patient's abdominal
pain resolved in less than 24 h with carbohydrate (glucose) loading
and highly caloric diet. Therefore, intravenous heminwas not necessary
at that time. She was discharged home in stable conditions and offered
to follow up at a porphyria center of her choice for further conﬁrmatory
genetic testing, management, and counseling. The patient was seen in
our epilepsy outpatient clinic one month later. She was not taking any
medications. She was asymptomatic, and her neurological exam was
normal. A follow-up brain MRI showed remarkable improvement.
3. Discussion
The neurological manifestations of AIP are potentially life-threaten-
ing without proper diagnosis, management, and elimination of triggers.Fig. 2. EEG, bipolar longitudinal montage, shows lateralized periodic discharges pWe report an unusual case of AIP presenting with PRES, seizures, and
LPDs + F, which led to additional complexity in the differential diagno-
sis and management of this patient.
The clinical presentation of our patient ﬁts the diagnosis of PRES,
which usually leads to altered consciousness and seizures. Neuroimag-
ing studies, including head CT and brain MRI, conﬁrm the diagnosis of
PRES and typically show bilateral symmetrical brain edemamore prom-
inent but not limited to the parietal and occipital regions. The cEEG
monitoring showed LPDs + F, which are usually seen as a result of
acute or subacute brain lesions, including stroke, infections, particularly
Herpes Simplex encephalitis, and rapidly growing brain tumors, but can
also be found in chronic epilepsy. More recently, LPDs have been
described in patients with PRES [4]. Skiba et al. emphasized the
importance of cEEGmonitoring to diagnose LPDs and recurrent seizures
in patients who present with PRES, once these patients may need
treatment with antiseizure drugs during the acute period [4].
Our patient improved clinically with supportive care and treatment
that target tight blood pressure control. The only remaining symptom
that raised the diagnostic possibility of acute porphyria a few dayslus fast activity (LPDs + F) over the right temporoparietal–occipital region.
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gy. Taken together, her symptoms of recurrent abdominal pain, nausea
and vomiting, tachycardia, and hypertension, which were likely exacer-
bated by fasting and infection, leading to encephalopathy and seizures,
were suggestive of an acute porphyria attack [1]. Exacerbation of acute
porphyrias is usually secondary tomultiple environmental andphysiolog-
ical factors, including drugs, infection, hormonal changes, or fasting [1].
When acute porphyria is suspected, screening for urinary PBG is
tested ﬁrst because these intermediates are increased in the urine of
all three most common acute porphyrias, including AIP, hereditary
coproporphyria (HCP), and variegate porphyria (VP), [1]. The patient's
urinary PBG was highly elevated and suggestive of an acute porphyria.
In an attempt to further differentiate the acute porphyrias, we request-
ed serumand fecal porphyrin levels. Ourﬁndings ofmarkedly increased
urine PBG levels, slightly increased plasma porphyrin levels, and normal
fecal porphyrin levels were suggestive of AIP. Acute intermittent
porphyria is the commonest acute porphyria.
It is likely that PRES is a contributing factor to the occurrence of
seizures in patients with AIP [5]. Seizures are not uncommon and occur
in up to 10–20% of patients at any time during the attacks of AIP [6]. Of
note is the fact that several antiseizure drugs, including phenytoin, carba-
mazepine, primidone, and valproic acid, are considered unsafe and may
provoke or worsen an attack of porphyria [1]. Fortunately, our patient,
who had no deﬁnite diagnosis at presentation, received levetiracetam
in the emergent setting, which was previously used with success for
the management of status epilepticus in a patient with AIP [7].
4. Conclusions
This case illustrates that the diagnosis of AIPmay be challenging. Her
initial symptoms including peaks of hypertension, encephalopathy, andseizures could be explained by PRES. The ﬁnding of LPDs + F over the
temporoparietal region on cEEG was likely secondary to PRES. The
initial question asked was what caused PRES in this young patient. It
was the presence of persistent abdominal pain without a deﬁnite etiol-
ogy that led to the diagnosis of an acute intermittent porphyria.Conﬂict of interest
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